glp 1 in india GLP-1 Drugs India: Growing Use for Diabetes and Weight Loss Raises Safety and Regulation Concerns GLP-1 Drugs Boom in India: Benefits, Side Effects & Government Crackdown Explained Ahead of its time, a
Description
Expected Ozempic-like results
All authors reviewed and approved the final version of the manuscript
GLP-1 0.8% HR 7.64, 95% CI 2.21-26.36 710 979 Cai et al., 2025 JAMA Ophthalmology 14 OHDSI 3,710 Semaglutide NAION 8.7-14.5 / 100,000 dulaglutideempagliflozinsitagliptin semaglutide vs
Reference: Willard FS et al
This kind of shortcut puts both safety and long-term health goals at risk
A: Semaglutide is a drug class which includes the brands Ozempic and Wegovy
